Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease

Introduction : Deep remission, defined as clinical remission with mucosal healing (MH), with anti-tumor necrosis factor (TNF)-α agents is a new target for therapy in Crohn’s disease (CD). Provided that the efficacy of infliximab (IFX) for induction of MH in CD has been demonstrated, there are much l...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Edyta Szymanska, Maciej Dadalski, Wieslawa Grajkowska, Sylwia Szymanska, Maciej Pronicki, Jaroslaw Kierkus
Формат: Artigo
Язык:Inglês
Опубликовано: Termedia Publishing House 2016-12-01
Серии:Gastroenterology Review
Предметы:
adalimumab
deep remission
mucosal healing
Crohn’s disease
Online-ссылка:https://www.termedia.pl/Adalimumab-for-endoscopic-and-histopathological-mucosal-healing-in-paediatric-patients-with-moderate-to-severe-Crohn-s-disease,41,28947,1,1.html
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы